FEops
FEops is a medtech company specializing in AI-based, cloud-based structural heart procedure planning through its FEops HEARTguide™ platform. The platform uses predictive simulation technology and artificial intelligence to analyze cardiac CT scans, providing physicians with detailed anatomical measurements and insights to improve procedure efficiency and outcomes for structural heart interventions such as left atrial appendage occlusion (LAAO) and transcatheter aortic valve implantation (TAVI). FEops HEARTguide™ enables personalized treatment planning by predicting device interaction with patient anatomy, reducing procedural complications and improving success rates. The company serves a global market with presence in 38 countries, 434 hospitals, and over 10,465 patients, positioning itself as a leader in AI-driven cardiovascular procedure planning. FEops also supports cardiovascular device companies with finite element analysis services to accelerate R&D.
FEops
FEops is a medtech company specializing in AI-based, cloud-based structural heart procedure planning through its FEops HEARTguide™ platform. The platform uses predictive simulation technology and artificial intelligence to analyze cardiac CT scans, providing physicians with detailed anatomical measurements and insights to improve procedure efficiency and outcomes for structural heart interventions such as left atrial appendage occlusion (LAAO) and transcatheter aortic valve implantation (TAVI). FEops HEARTguide™ enables personalized treatment planning by predicting device interaction with patient anatomy, reducing procedural complications and improving success rates. The company serves a global market with presence in 38 countries, 434 hospitals, and over 10,465 patients, positioning itself as a leader in AI-driven cardiovascular procedure planning. FEops also supports cardiovascular device companies with finite element analysis services to accelerate R&D.